NOTIFICATION OF REMOVAL FROM LISTING AND/OR REGISTRATION UNDER SECTION 12(b) OF THE SECURITIES EXCHANGE ACT OF 1934. Commission File Number 001-38723
Issuer: Tiziana Life Sciences plc
Exchange: Nasdaq Stock Market LLC
(Exact name of Issuer as specified in its charter, and name of Exchange where security is listed and/or registered)
Address: 9th Floor, 107 Cheapside
London,
UNITED KINGDOM
EC2V 6DN
Telephone number: +44 (0) 207 495 2379
(Address, including zip code, and telephone number, including area code, of Issuer's principal executive offices)
Tiziana Life Sciences plc American Depositary Shares
(Description of class of securities)
Please place an X in the box to designate the rule provision relied upon to strike the class of securities from listing and registration:
o 17 CFR 240.12d2-2(a)(1)
o 17 CFR 240.12d2-2(a)(2)
x 17 CFR 240.12d2-2(a)(3)
o 17 CFR 240.12d2-2(a)(4)
o  Pursuant to 17 CFR 240.12d2-2(b), the Exchange has complied with its rules to strike the class of securities from listing and/or withdraw registration on the Exchange. 1
o  Pursuant to 17 CFR 240.12d2-2(c), the Issuer has complied with its rules of the Exchange and the requirements of 17 CFR 240.12d-2(c) governing the voluntary withdrawal of the class of securities from listing and registration on the Exchange.
Pursuant to the requirements for the Securities Exchange Act of 1934, Nasdaq Stock Market LLC certifies that it has reasonable grounds to believe that it meets all of the requirements for filing the Form 25 and has caused this notification to be signed on its behalf by the undersigned duly authorized person.
2021-10-20ByTara PettaAVP - Securities Operations
Date NameTitle
1 Form 25 and attached Notice will be considered compliance with the provisions of 17 CFR 240.19d-1 as applicable. See General Instructions.
Tiziana Life Sciences (NASDAQ:TLSA)
Gráfica de Acción Histórica
De May 2024 a Jun 2024 Haga Click aquí para más Gráficas Tiziana Life Sciences.
Tiziana Life Sciences (NASDAQ:TLSA)
Gráfica de Acción Histórica
De Jun 2023 a Jun 2024 Haga Click aquí para más Gráficas Tiziana Life Sciences.

Noticias sobre Tiziana Life Sciences Plc TLSA

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Martes 11 de Junio 2024 (2 semanas hace) • Edgar (US Regulatory)
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Jueves 6 de Junio 2024 (3 semanas hace) • Edgar (US Regulatory)
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Martes 4 de Junio 2024 (3 semanas hace) • Edgar (US Regulatory)
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Jueves 30 de Mayo 2024 (4 semanas hace) • Edgar (US Regulatory)
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Lunes 13 de Mayo 2024 (1 mes hace) • Edgar (US Regulatory)
Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
Viernes 10 de Mayo 2024 (2 meses hace) • Edgar (US Regulatory)
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Martes 5 de Marzo 2024 (4 meses hace) • Edgar (US Regulatory)
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Lunes 8 de Enero 2024 (6 meses hace) • Edgar (US Regulatory)
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Viernes 5 de Enero 2024 (6 meses hace) • Edgar (US Regulatory)
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Viernes 5 de Enero 2024 (6 meses hace) • Edgar (US Regulatory)
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Viernes 29 de Diciembre 2023 (6 meses hace) • Edgar (US Regulatory)
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Martes 19 de Diciembre 2023 (6 meses hace) • Edgar (US Regulatory)

Más de Tiziana Life Sciences Plc Artículos de Noticias

Su Consulta Reciente

Delayed Upgrade Clock